Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Gotistobart Trial for NSCLC on Partial Clinical Hold
The US Food and Drug Administration (FDA) has placed a partial clinical hold on the phase 3 PRESERVE-003 trial of BNT316/ONC-392 (gotistobart, BioNTech and OncoC4) for non–small cell lung cancer (NSCLC) due to varying results in patients with squamous and…
English